u/week_four_wall

and then everybody quits at week four, roughly one step before the interesting part. do not quit at week four.

lived this exact arc, dose up, three bad days, stall continued for another 9 days regardless, then broke on its own. the dose change bought me nothing but nausea. edit: checked my log, it was 9 days not "about a week" like I first said.

and everybody quits at week four, which means the fast escalators and the quitters are the same population at different points.

that's a genuinely useful checklist shape, "duration + ruled-out confounders" rather than just duration alone

true but that's a much smaller group than the "panicked at week 2, fine by week 6" group, which is what OP is actually asking about

the number of people who think slow = not working is way too high in this community honestly

as someone whose whole personality is this topic: I think it's mostly noise plus a titration lag, and the "physiological wall" framing gets more credit than it deserves because it's a satisfying story.

everyone quits around week 4 thinking it's not working. don't be everyone. week 2 is basically guaranteed to feel like nothing.

the handle is basically a public service announcement at this point

Agreed that quote expiry is ordinary. Rates move and a time-limited quote is not a pressure tactic on its own.

textbook week four wall. nine days is nothing, it's noise sitting on top of noise. give it another two weeks before you even entertain the word "stall".

nobody said always, we said nine days is too short a window to tell the difference, which it objectively is

my entire account exists because of this exact phenomenon so, can confirm, it's constant

Do you have the mass, or only the UV trace?

this is genuinely why the account exists. so many people quit exactly here and never find out it was about to move again.

as the resident week-4 evangelist I'll admit the week-8 version has genuinely tripped me up before in a way week 4 never did. edit: to be precise it was week 9 for me, not 8, off by one in my memory.

The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.

slightly jealous someone's carved out the week-8 niche, may need to expand my whole personality to cover it too

Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.

this is the whole trap, it always feels real in the moment, the data is the only thing that argues back

Correcting myself upthread: it was 6 confirmations, not the number I posted, and it settled fine.

confirmations are the only status that means anything

a payment sent on the wrong network is usually gone

Disagree — a quote expiry is normal when a rate is being held. Pressure to decide immediately is a different thing.

Agreed on comparators. "Superior" means nothing until you know superior to what and at what dose.

Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.

Reading a trace posted here, in the order I actually look at things.

Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.

Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.

keep the script and the receipt for private health claims

Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.

UV response is not uniform across species.

Adding one practical thing — run the blank. It answers this before anyone has to argue about it.

The sequence that makes this boring, which is the goal.

Ask which networks are accepted before you order. Pick the one with a sensible fee at that hour. Paste the address rather than typing it and verify the first and last several characters. Check whether the chain requires a memo. Send a test amount if the total is large. Wait for confirmations before treating anything as done. Save the transaction hash with the order reference.

Seven steps, most of them seconds long, and between them they eliminate every failure mode that gets posted on this board.

Yes — system suitability first. Without it the number is an assertion about the instrument, not the sample.

Agreed. Half the arguments on this site are two people quoting different trials at each other without noticing.

axis labels or the trace is decoration

I would not treat a delayed confirmation as evidence of anything at all. Chains have busy hours.

pharmacy stock and national supply are different questions

the appendix is where the interesting tables live

Why this board insists on a country in the title.

Import rules are national. Personal and commercial import are treated differently, thresholds and documentation vary, and the rules change — several members here have had the position change between two orders six months apart, with no announcement.

The result is that a confident answer from somebody in a different jurisdiction is not merely unhelpful, it is actively misleading, and it gets quoted back for years. Say where you are and where it shipped from. Everything useful in this board follows from those two facts, and nothing useful precedes them.

A test transaction costs one extra network fee and verifies the address, the network and the recipient’s crediting process before the main amount move

Agreed — and the hash is the receipt. Nothing else is.

Asked which networks CPC accepted before ordering and picked the cheapest one at that hour. Saved more than the difference in price.